UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neuroendocrine Tumors: a Relevant Clinical Update

Current oncology reports, 2022-06, Vol.24 (6), p.703-714

2022

Volltextzugriff (PDF)

Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study

The lancet oncology, 2015-06, Vol.16 (6), p.695-703

2015

Volltextzugriff (PDF)

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study

Endocrine-related cancer, 2016-03, Vol.23 (3), p.191-199

2016

Volltextzugriff (PDF)

The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas

Pancreas, 2010-08, Vol.39 (6), p.799-800

2010

Volltextzugriff (PDF)

Consensus guidelines for the management and treatment of neuroendocrine tumors

Pancreas, 2013-05, Vol.42 (4), p.557

2013

Volltextzugriff (PDF)

Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population

Pancreas, 2012-04, Vol.41 (3), p.461-466

2012

Volltextzugriff (PDF)

Immunotherapy and targeted therapy-the new roadmap in cancer treatment

Annals of translational medicine, 2019-10, Vol.7 (20), p.595-595

2019

Volltextzugriff (PDF)

Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study

Endocrine, 2021-02, Vol.71 (2), p.502-513

2021

Volltextzugriff (PDF)

Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma

Clinical gastroenterology and hepatology, 2017-11, Vol.15 (11), p.1791-1799

2017

Volltextzugriff (PDF)

Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma

Gastroenterology (New York, N.Y. 1943), 2015-07, Vol.149 (1), p.119-129

2015

Volltextzugriff (PDF)

Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumors

Pancreas, 2015-03, Vol.44 (2), p.190-197

2015

Volltextzugriff (PDF)

Molecular pathways and targeted therapy in cholangiocarcinoma

Clinical advances in hematology & oncology, 2019-11, Vol.17 (11), p.630-637

2019

Volltextzugriff (PDF)

Emerging treatment options for patients with gastroenteropancreatic neuroendocrine tumors

Clinical advances in hematology & oncology, 2017-04, Vol.15 Suppl 4 (4), p.10-14

Phan, Alexandria T

2017

Volltextzugriff (PDF)

Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus Mitotane

Annals of surgical oncology, 2010, Vol.17 (1), p.263-270

2010

Volltextzugriff (PDF)

Epidemiological risk factors for adrenocortical carcinoma: A hospital‐based case–control study

International journal of cancer, 2020-04, Vol.146 (7), p.1836-1840

2020

Volltextzugriff (PDF)

Population-based study of islet cell carcinoma

Annals of surgical oncology, 2007-12, Vol.14 (12), p.3492-3500

2007

Volltextzugriff (PDF)

Resection of At-Risk Mesenteric Lymph Nodes Is Associated with Improved Survival in Patients with Small Bowel Neuroendocrine Tumors

World journal of surgery, 2013-07, Vol.37 (7), p.1695-1700

2013

Volltextzugriff (PDF)

Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center

Leukemia & lymphoma, 2017-09, Vol.58 (9), p.2110-2117

2017

Volltextzugriff (PDF)

The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors

Cancer medicine (Malden, MA), 2016-10, Vol.5 (10), p.2953-2964

2016

Volltextzugriff (PDF)

Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors

Journal of gastrointestinal cancer, 2016-12, Vol.47 (4), p.366-374

2016

Volltextzugriff (PDF)

Stereotactic body radiation therapy and immunotherapy

Clinical advances in hematology & oncology, 2019-09, Vol.17 (9), p.518-523

2019

Volltextzugriff (PDF)

NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus)

Pancreas, 2010-08, Vol.39 (6), p.784-798

2010

Volltextzugriff (PDF)

Effect of Lanreotide Depot/Autogel on Urinary 5‐Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors

The oncologist (Dayton, Ohio), 2019-04, Vol.24 (4), p.463-474

2019

Volltextzugriff (PDF)

Neuroendocrine Tumors and Lanreotide Depot: Clinical Considerations and Nurse and Patient Preferences

Clinical journal of oncology nursing, 2016-12, Vol.20 (6), p.E139-E146

2016

Volltextzugriff (PDF)

Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors

Journal of health economics and outcomes research (Online), 2023-12, p.121-131

2023

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(132)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(60)
Humans
(59)
Female
(38)
Oncology
(38)
Male
(36)
Middle Aged
(33)
Aged
(30)
Adult
(24)
Neuroendocrine Tumors
(18)
Treatment Outcome
(17)
Retrospective Studies
(14)
Neuroendocrine Tumors - Drug Therapy
(12)
Prognosis
(12)
Gastroenterology & Hepatology
(11)
Neoplasm Staging
(11)
Surgery
(11)
Aged, 80 And Over
(10)
Antineoplastic Agents - Therapeutic Use
(10)
Medicine
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neuroendocrine Tumors: a Relevant Clinical Update

Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study

The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas

Consensus guidelines for the management and treatment of neuroendocrine tumors

Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population

Immunotherapy and targeted therapy-the new roadmap in cancer treatment

Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study

Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma

Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma

Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumors

Molecular pathways and targeted therapy in cholangiocarcinoma

Emerging treatment options for patients with gastroenteropancreatic neuroendocrine tumors

Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus Mitotane

Epidemiological risk factors for adrenocortical carcinoma: A hospital‐based case–control study

Population-based study of islet cell carcinoma

Resection of At-Risk Mesenteric Lymph Nodes Is Associated with Improved Survival in Patients with Small Bowel Neuroendocrine Tumors

Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center

The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors

Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors

Stereotactic body radiation therapy and immunotherapy

NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus)

Effect of Lanreotide Depot/Autogel on Urinary 5‐Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors

Neuroendocrine Tumors and Lanreotide Depot: Clinical Considerations and Nurse and Patient Preferences

Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors

Aktive Filter

Suchergebnisse filtern